We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$1.31B
AUM Growth
+$305M
Cap. Flow
+$326M
Cap. Flow %
24.94%
Top 10 Hldgs %
40.19%
Holding
87
New
20
Increased
35
Reduced
4
Closed
23

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$37.6M
2
SGI
Somnigroup International
SGI
+$37.3M
3
AMAG
AMAG Pharmaceuticals
AMAG
+$32.2M
4
PRKS icon
United Parks & Resorts
PRKS
+$29.4M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$27.3M

Top Sells

Rank Stock Value
1
ENR icon
Energizer
ENR
+$29.4M
2
CMG icon
Chipotle Mexican Grill
CMG
+$22.5M
3
GSK icon
GSK
GSK
+$14.6M
4
GME icon
GameStop
GME
+$14.4M
5
BJRI icon
BJ's Restaurants
BJRI
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 46.43%
2 Consumer Discretionary 25.02%
3 Miscellaneous 18.11%
4 Consumer Staples 9.24%
5 Financials 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMRX
51
DELISTED
Chimerix, Inc.
CMRX
$5.36M 0.41%
+1,031,200
New +$5.22M
IPCI
52
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$4.89M 0.37%
860,000
+666,400
+344% +$4.82M
FRTX
53
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$3.33M 0.26%
7,302
+953
+15% +$473K
NOVN
54
DELISTED
Novan, Inc. Common Stock
NOVN
$2.93M 0.22%
+100,000
New +$3.35M
ATNM icon
55
Actinium Pharmaceuticals
ATNM
$37.6M
$2.23M 0.17%
203,333
+54,533
+37% +$927K
BDSI
56
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.8M 0.14%
+800,000
New +$1.87M
DYNT
57
DELISTED
Dynatronics Corp
DYNT
$1.6M 0.12%
106,384
+2,006
+2% +$29K
SCYX icon
58
SCYNEXIS
SCYX
$51.2M
$1.34M 0.1%
+12,500
New +$1.72M
TRAW icon
59
Traws Pharma
TRAW
$8.58M
$1.13M 0.09%
+240
New +$1.71M
AYTU icon
60
AYTU BioPharma
AYTU
$23.8M
$956K 0.07%
375
+283
+308% +$1.95M
PULM icon
61
Pulmatrix
PULM
$4.97M
$835K 0.06%
+8,200
New +$2.35M
SEEL
62
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$796K 0.06%
17
+10
+143% +$1.91M
AIXC
63
AIxCrypto Holdings Inc
AIXC
$14.6M
$517K 0.04%
15
– –
KPRX icon
64
Kiora Pharmaceuticals
KPRX
$11.3M
$453K 0.03%
221
-17
-7% -$73.5K
BJRI icon
65
BJ's Restaurants
BJRI
$1.3B
– –
-384,000
Closed -$14M
MBAI
66
MBody AI Ltd. Ordinary Share
MBAI
$8.83M
– –
-445
Closed -$651K
CMG icon
67
Chipotle Mexican Grill
CMG
$46.8B
– –
-3,900,000
Closed -$22.5M
DKS icon
68
CALL
Dick's Sporting Goods
DKS
$11.8B
– –
-200,000
Closed -$5.75M
EBAY icon
69
eBay
EBAY
$46.6B
– –
-264,000
Closed -$9.96M
ENR icon
70
Energizer
ENR
$1.45B
– –
-612,000
Closed -$29.4M
GME icon
71
GameStop
GME
$8.48B
– –
-3,200,000
Closed -$14.4M
GSK icon
72
GSK
GSK
$97.4B
– –
-329,600
Closed -$14.6M
IRBT
73
DELISTED
iRobot
IRBT
– –
-128,000
Closed -$9.82M
PAG icon
74
Penske Automotive Group
PAG
$14.3B
– –
-212,000
Closed -$10.1M
PZZA icon
75
Papa John's
PZZA
$747M
– –
-172,000
Closed -$10.3M
1 2
3
4

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q1 2018 Portfolio in Review

As of Q1 2018, Armistice Capital held 87 positions worth $1.31B, up 30% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Armistice Capital deployed $326M of net new capital in Q1 2018, opening 20 new positions and adding to 35 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 108,000 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.

On the sell side, the largest reduction was Vanda Pharmaceuticals, an estimated $1.31M trimmed.

  • Armistice Capital's largest Q1 2018 buy was Regeneron Pharmaceuticals: 108,000 shares worth $37.2M.
  • Armistice Capital added most to United Therapeutics in Q1 2018, an estimated $23.9M increase.
  • Armistice Capital's biggest Q1 2018 reduction was Vanda Pharmaceuticals, cutting an estimated $1.31M.
  • Armistice Capital fully exited Energizer in Q1 2018, selling an estimated $29.4M.
  • Armistice Capital's ten largest holdings make up 40% of its $1.31B portfolio in Q1 2018.
  • Armistice Capital opened 20 new positions and closed 23 in Q1 2018.
  • Armistice Capital's portfolio value rose 30% quarter-over-quarter to $1.31B.

Based on Armistice Capital's 13F filing for Q1 2018, filed 15 May 2018.